2024 Q1 Form 10-K Financial Statement

#000095017024035099 Filed on March 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $5.080M $19.46M
YoY Change 9.2% 17.73%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $150.0K $119.0K $512.0K
YoY Change 17.19% 250.0% 9.4%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $1.559M $4.277M
YoY Change 105.4% 213.33%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $897.0K $997.0K $5.050M
YoY Change -33.9% -6.21% -4.43%
Income Tax $183.0K $167.0K $1.097M
% Of Pretax Income 20.4% 16.75% 21.72%
Net Earnings $714.0K $819.0K $3.953M
YoY Change -29.66% -16.85% -5.5%
Net Earnings / Revenue 14.06% 20.31%
Basic Earnings Per Share $0.11 $0.56
Diluted Earnings Per Share $0.11 $0.11 $0.54
COMMON SHARES
Basic Shares Outstanding 7.266M 7.257M 6.921M
Diluted Shares Outstanding 6.783M 7.179M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $17.35M $13.04M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $15.36M $13.96M $13.96M
YoY Change 42.89% 28.62% 28.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $563.0K $1.169M $2.440M
YoY Change -59.61% 5.13% 11.21%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $420.7M $411.6M $411.6M
YoY Change 0.77% -2.74% -2.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $381.0K $239.0K $239.0K
YoY Change 152.32% 54.19% 54.19%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $381.0K $239.0K $239.0K
YoY Change 152.32% 54.19% 54.19%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.578M $5.666M $5.666M
YoY Change 4.32% 14.63% 14.63%
Total Long-Term Liabilities $5.578M $5.666M $5.666M
YoY Change 4.32% 14.63% 14.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $381.0K $239.0K $239.0K
Total Long-Term Liabilities $5.578M $5.666M $5.666M
Total Liabilities $319.4M $309.9M $309.9M
YoY Change 0.77% -4.07% -4.07%
SHAREHOLDERS EQUITY
Retained Earnings $59.18M $59.34M
YoY Change 4.92% 4.92%
Common Stock $48.04M $48.15M
YoY Change -4.37% -4.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $101.3M $101.7M $101.7M
YoY Change
Total Liabilities & Shareholders Equity $420.7M $411.6M $411.6M
YoY Change 0.77% -2.74% -2.74%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $714.0K $819.0K $3.953M
YoY Change -29.66% -16.85% -5.5%
Depreciation, Depletion And Amortization $150.0K $119.0K $512.0K
YoY Change 17.19% 250.0% 9.4%
Cash From Operating Activities $1.661M $474.0K $5.861M
YoY Change 13.22% -7.42% 1.61%
INVESTING ACTIVITIES
Capital Expenditures $1.531M $2.088M $3.630M
YoY Change 3727.5% 178.4% 108.26%
Acquisitions
YoY Change
Other Investing Activities -$4.001M -$1.261M -$8.263M
YoY Change 39.75% -84.11% -91.38%
Cash From Investing Activities -$5.532M -$3.349M -$11.89M
YoY Change 90.56% -61.45% -87.81%
FINANCING ACTIVITIES
Cash Dividend Paid $876.0K $886.0K
YoY Change -1.13% -0.34%
Common Stock Issuance & Retirement, Net $2.870M
YoY Change 2159.84%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.188M -6.890M -17.58M
YoY Change -208.98% -142.87% -126.43%
NET CHANGE
Cash From Operating Activities 1.661M 474.0K 5.861M
Cash From Investing Activities -5.532M -3.349M -11.89M
Cash From Financing Activities 8.188M -6.890M -17.58M
Net Change In Cash 4.317M -9.765M -23.61M
YoY Change -148.24% -223.67% -6.66%
FREE CASH FLOW
Cash From Operating Activities $1.661M $474.0K $5.861M
Capital Expenditures $1.531M $2.088M $3.630M
Free Cash Flow $130.0K -$1.614M $2.231M
YoY Change -90.89% 578.15% -44.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001845799
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q2 dei Entity Public Float
EntityPublicFloat
0
CY2022 cull Provision For Unfunded Commitments
ProvisionForUnfundedCommitments
CY2023 cull Payment To Acquire Equity
PaymentToAcquireEquity
CY2023Q4 us-gaap Federal Funds Sold
FederalFundsSold
8650000
CY2022Q4 us-gaap Federal Funds Sold
FederalFundsSold
30225000
CY2023Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
13036000
CY2022Q4 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
36645000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OperatingLeaseLiability
CY2023 us-gaap Operating Lease Income Comprehensive Income Extensible List
OperatingLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#NetIncomeLoss
CY2022 us-gaap Operating Lease Income Comprehensive Income Extensible List
OperatingLeaseIncomeComprehensiveIncomeExtensibleList
http://fasb.org/us-gaap/2023#NetIncomeLoss
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-40607
CY2023 dei Entity Registrant Name
EntityRegistrantName
Cullman Bancorp, Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1990996
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
316 Second Avenue
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
S.W
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Cullman
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
AL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
35055
CY2023 dei City Area Code
CityAreaCode
256
CY2023 dei Local Phone Number
LocalPhoneNumber
734-1740
CY2023 dei Security12b Title
Security12bTitle
Common stock
CY2023 dei Trading Symbol
TradingSymbol
CULL
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7265689
CY2023 dei Auditor Firm
AuditorFirmId
173
CY2023 dei Auditor Name
AuditorName
Crowe LLP
CY2023 dei Auditor Location
AuditorLocation
Atlanta, Georgia
CY2023Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
229000
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
434000
CY2023Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
4157000
CY2022Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
5986000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
28356000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
29796000
CY2023Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
0
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
479000
CY2023Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3271000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2841000
CY2023Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
339402000
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
329943000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13957000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10851000
CY2023Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
0
CY2022Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
50000
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
1260000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
1162000
CY2023Q4 us-gaap Equity Securities Fv Ni Restricted
EquitySecuritiesFvNiRestricted
2782000
CY2022Q4 us-gaap Equity Securities Fv Ni Restricted
EquitySecuritiesFvNiRestricted
2033000
CY2023Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
9239000
CY2022Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
8964000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2440000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2194000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1169000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1112000
CY2023Q4 us-gaap Assets
Assets
411641000
CY2022Q4 us-gaap Assets
Assets
423229000
CY2023Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
12297000
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
16281000
CY2023Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
256704000
CY2022Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
276668000
CY2023Q4 us-gaap Deposits
Deposits
269001000
CY2022Q4 us-gaap Deposits
Deposits
292949000
CY2023Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
35000000
CY2022Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
25000000
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
239000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
155000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5666000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4943000
CY2023Q4 us-gaap Liabilities
Liabilities
309906000
CY2022Q4 us-gaap Liabilities
Liabilities
323047000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7301282
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7394615
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
71000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
74000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
48081000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
50161000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
59344000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
56561000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2913000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3558000
CY2023Q4 us-gaap Unearned Esop Shares
UnearnedESOPShares
2848000
CY2022Q4 us-gaap Unearned Esop Shares
UnearnedESOPShares
3056000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
101735000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
100182000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
411641000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
423229000
CY2023 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
17348000
CY2022 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
15202000
CY2023 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
27000
CY2022 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
32000
CY2023 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
922000
CY2022 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
816000
CY2023 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
1162000
CY2022 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
479000
CY2023 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
19459000
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
16529000
CY2023 us-gaap Interest Expense Customer Deposits
InterestExpenseCustomerDeposits
2855000
CY2022 us-gaap Interest Expense Customer Deposits
InterestExpenseCustomerDeposits
1055000
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
1422000
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
310000
CY2023 us-gaap Interest Expense
InterestExpense
4277000
CY2022 us-gaap Interest Expense
InterestExpense
1365000
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
15182000
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
15164000
CY2023 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
166000
CY2022 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
438000
CY2023 cull Provision For Unfunded Commitments
ProvisionForUnfundedCommitments
128000
CY2023 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
14888000
CY2022 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
14726000
CY2023 cull Service Charges On Deposit Accounts
ServiceChargesOnDepositAccounts
1097000
CY2022 cull Service Charges On Deposit Accounts
ServiceChargesOnDepositAccounts
1023000
CY2023 us-gaap Premiums Earned Net
PremiumsEarnedNet
275000
CY2022 us-gaap Premiums Earned Net
PremiumsEarnedNet
227000
CY2023 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
22000
CY2022 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
86000
CY2023 cull Gain Loss On Prepayment Of Federal Home Loan Bank Advances
GainLossOnPrepaymentOfFederalHomeLoanBankAdvances
127000
CY2022 cull Gain Loss On Prepayment Of Federal Home Loan Bank Advances
GainLossOnPrepaymentOfFederalHomeLoanBankAdvances
87000
CY2023 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-6000
CY2022 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
39000
CY2023 us-gaap Noninterest Income Other
NoninterestIncomeOther
195000
CY2022 us-gaap Noninterest Income Other
NoninterestIncomeOther
224000
CY2023 us-gaap Noninterest Income
NoninterestIncome
1710000
CY2022 us-gaap Noninterest Income
NoninterestIncome
1686000
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7786000
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7594000
CY2023 cull Occupancy And Equipment Expenses
OccupancyAndEquipmentExpenses
982000
CY2022 cull Occupancy And Equipment Expenses
OccupancyAndEquipmentExpenses
937000
CY2023 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1003000
CY2022 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
864000
CY2023 cull Professional And Supervisory Fees
ProfessionalAndSupervisoryFees
883000
CY2022 cull Professional And Supervisory Fees
ProfessionalAndSupervisoryFees
779000
CY2023 cull Office Expense
OfficeExpense
166000
CY2022 cull Office Expense
OfficeExpense
201000
CY2023 cull Advertising Expense Or Refund
AdvertisingExpenseOrRefund
119000
CY2022 cull Advertising Expense Or Refund
AdvertisingExpenseOrRefund
179000
CY2023 cull Federal Deposit Insurance Corporation Expense Rebates
FederalDepositInsuranceCorporationExpenseRebates
162000
CY2022 cull Federal Deposit Insurance Corporation Expense Rebates
FederalDepositInsuranceCorporationExpenseRebates
76000
CY2023 us-gaap Other Noninterest Expense
OtherNoninterestExpense
447000
CY2022 us-gaap Other Noninterest Expense
OtherNoninterestExpense
498000
CY2023 us-gaap Noninterest Expense
NoninterestExpense
11548000
CY2022 us-gaap Noninterest Expense
NoninterestExpense
11128000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5050000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5284000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1097000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1101000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
3953000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
4183000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2023 us-gaap Net Income Loss
NetIncomeLoss
3953000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
4183000
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
612000
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4854000
CY2023 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-33000
CY2022 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-1019000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
645000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3835000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4598000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
348000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
99734000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
4183000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3835000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
127000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
560000
CY2022 us-gaap Dividends
Dividends
889000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
556000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
100182000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
100182000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
3953000
CY2023 cull Current Expected Credit Loss Implementation
CurrentExpectedCreditLossImplementation
-284000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
645000
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
2870000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
222000
CY2023 us-gaap Dividends
Dividends
886000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
773000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
101735000
CY2023 us-gaap Profit Loss
ProfitLoss
3953000
CY2022 us-gaap Profit Loss
ProfitLoss
4183000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
294000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
438000
CY2023 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
469000
CY2022 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
335000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-119000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
148000
CY2023 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0
CY2022 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
46000
CY2023 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-12000
CY2022 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
18000
CY2023 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
18000
CY2022 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-24000
CY2023 cull Gain Loss On Sale Of Repossessions
GainLossOnSaleOfRepossessions
-3000
CY2022 cull Gain Loss On Sale Of Repossessions
GainLossOnSaleOfRepossessions
-3000
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
127000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
87000
CY2023 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
275000
CY2022 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
227000
CY2023 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
22000
CY2022 us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
86000
CY2023 cull Mortgage Loans Originated For Sale
MortgageLoansOriginatedForSale
714000
CY2022 cull Mortgage Loans Originated For Sale
MortgageLoansOriginatedForSale
3261000
CY2023 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
736000
CY2022 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
3347000
CY2023 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
222000
CY2022 us-gaap Employee Stock Ownership Plan Esop Compensation Expense
EmployeeStockOwnershipPlanESOPCompensationExpense
560000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
773000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
556000
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
98000
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
387000
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
84000
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
95000
CY2023 us-gaap Increase Decrease In Other Current Assets And Liabilities Net
IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet
-688000
CY2022 us-gaap Increase Decrease In Other Current Assets And Liabilities Net
IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet
-191000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5861000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5768000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3630000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1743000
CY2023 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
0
CY2022 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
3000000
CY2023 cull Payment To Acquire Available For Sale Securities
PaymentToAcquireAvailableForSaleSecurities
0
CY2022 cull Payment To Acquire Available For Sale Securities
PaymentToAcquireAvailableForSaleSecurities
16063000
CY2023 cull Proceeds From Maturities Paydowns And Calls Of Securities
ProceedsFromMaturitiesPaydownsAndCallsOfSecurities
2096000
CY2022 cull Proceeds From Maturities Paydowns And Calls Of Securities
ProceedsFromMaturitiesPaydownsAndCallsOfSecurities
2785000
CY2023 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
67000
CY2022 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
453000
CY2023 cull Payment For Purchase Of Restricted Equity Securities
PaymentForPurchaseOfRestrictedEquitySecurities
749000
CY2022 cull Payment For Purchase Of Restricted Equity Securities
PaymentForPurchaseOfRestrictedEquitySecurities
1868000
CY2022 cull Payment To Acquire Equity
PaymentToAcquireEquity
-694000
CY2023 cull Payments To Acquire Redemptions Of Equity Securities
PaymentsToAcquireRedemptionsOfEquitySecurities
-497000
CY2022 cull Payments To Acquire Redemptions Of Equity Securities
PaymentsToAcquireRedemptionsOfEquitySecurities
503000
CY2023 cull Payments For Proceeds From Loan Organisations
PaymentsForProceedsFromLoanOrganisations
10174000
CY2022 cull Payments For Proceeds From Loan Organisations
PaymentsForProceedsFromLoanOrganisations
78315000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11893000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-97560000
CY2023 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-23948000
CY2022 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
60928000
CY2023 us-gaap Proceeds From Federal Home Loan Bank Advances
ProceedsFromFederalHomeLoanBankAdvances
25000000
CY2022 us-gaap Proceeds From Federal Home Loan Bank Advances
ProceedsFromFederalHomeLoanBankAdvances
25000000
CY2023 cull Repayment Of Federal Home Loan Bank Advances
RepaymentOfFederalHomeLoanBankAdvances
14873000
CY2022 cull Repayment Of Federal Home Loan Bank Advances
RepaymentOfFederalHomeLoanBankAdvances
18413000
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
886000
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
889000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2870000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
127000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17577000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
66499000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-23609000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-25293000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36645000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61938000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13036000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36645000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
4193000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1270000
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
804000
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
645000
CY2023 cull Transfers For Loans To Foreclosed Assets
TransfersForLoansToForeclosedAssets
0
CY2022 cull Transfers For Loans To Foreclosed Assets
TransfersForLoansToForeclosedAssets
94000
CY2023 cull Impact Of Adoption Of Current Expected Credit Losses Methodology
ImpactOfAdoptionOfCurrentExpectedCreditLossesMethodology
-379000
CY2022 cull Impact Of Adoption Of Current Expected Credit Losses Methodology
ImpactOfAdoptionOfCurrentExpectedCreditLossesMethodology
0
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">: To prepare financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions based on available information. These estimates and assumptions affect the amounts reported in the financial statements and the disclosures provided, and actual results could differ.</span></p>
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:6.667%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concentration of Credit Risk</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">: Most of the Company's business activity is with customers located within Cullman County. Therefore, the Company's exposure to credit risk is significantly affected by changes in the economy in the Cullman County area.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2023Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
261000
CY2023Q1 cull Decrease In Retained Earnings
DecreaseInRetainedEarnings
284000
CY2023Q1 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
95000
CY2023Q1 us-gaap Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
379000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
32247000
CY2023 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
9000
CY2023 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
3900000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
28356000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
34299000
CY2022 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
14000
CY2022 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
4517000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
29796000
CY2023 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
75000
CY2022 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
90000
CY2023 cull Proceeds From Sales And Calls Of Securities Gross Gain
ProceedsFromSalesAndCallsOfSecuritiesGrossGain
0
CY2022 cull Proceeds From Sales And Calls Of Securities Gross Gain
ProceedsFromSalesAndCallsOfSecuritiesGrossGain
0
CY2023 cull Proceeds From Sales And Calls Of Securities Gross Loss
ProceedsFromSalesAndCallsOfSecuritiesGrossLoss
0
CY2022 cull Proceeds From Sales And Calls Of Securities Gross Loss
ProceedsFromSalesAndCallsOfSecuritiesGrossLoss
0
CY2023 cull Calls Of Securities
CallsOfSecurities
0
CY2022 cull Calls Of Securities
CallsOfSecurities
0
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
676000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
669000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
3491000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
3457000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
4074000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
3624000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
12999000
CY2023Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
10245000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
32247000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
28356000
CY2023Q4 us-gaap Deposit Liabilities Collateral Issued Financial Instruments
DepositLiabilitiesCollateralIssuedFinancialInstruments
9350000
CY2022Q4 us-gaap Deposit Liabilities Collateral Issued Financial Instruments
DepositLiabilitiesCollateralIssuedFinancialInstruments
26666000
CY2023Q4 cull Number Of Security Holdings Greater Than Ten Percent Of Equity
NumberOfSecurityHoldingsGreaterThanTenPercentOfEquity
0
CY2022Q4 cull Number Of Security Holdings Greater Than Ten Percent Of Equity
NumberOfSecurityHoldingsGreaterThanTenPercentOfEquity
0
CY2023 us-gaap Debt Securities Trading Unrealized Loss
DebtSecuritiesTradingUnrealizedLoss
0
CY2023Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
342681000
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
332794000
CY2023Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
8000
CY2022Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
10000
CY2023Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
3271000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
2841000
CY2023Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
339402000
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
329943000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2841000
CY2023 cull Impact Of Adopting
ImpactOfAdopting
246000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
11000
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
29000
CY2023 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
166000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
3271000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2406000
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
44000
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
41000
CY2022 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
438000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2841000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
0
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
2841000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
2841000
CY2022Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
2472000
CY2022Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
330322000
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
332794000
CY2022Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
2508000
CY2022Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
2472000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
0
CY2022 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
3217000
CY2022 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
155000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
342681000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
332794000
CY2023Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
0
CY2022Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
82000
CY2022 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
2878000
CY2022 cull Financing Receivable Additional Recorded Investment
FinancingReceivableAdditionalRecordedInvestment
0
CY2023 cull Financing Receivable Troubled Restructured Loans
FinancingReceivableTroubledRestructuredLoans
0
CY2023 cull Loan Modification Description
LoanModificationDescription
A loan is considered to be in payment default once it is 90 days contractually past due under the modified terms.
CY2023Q4 cull Internal Risk Rating Of Loan
InternalRiskRatingOfLoan
342681000
CY2022Q4 cull Internal Risk Rating Of Loan
InternalRiskRatingOfLoan
332794000
CY2023Q4 us-gaap Land
Land
1924000
CY2022Q4 us-gaap Land
Land
1924000
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
19264000
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
15668000
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2556000
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2623000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23744000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20215000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9787000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9364000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13957000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10851000
CY2023 us-gaap Depreciation
Depreciation
512000
CY2022 us-gaap Depreciation
Depreciation
468000
CY2023Q4 cull Fdic Insurance Limit
FDICInsuranceLimit
250000
CY2022Q4 cull Fdic Insurance Limit
FDICInsuranceLimit
250000
CY2023Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
36395000
CY2022Q4 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
32614000
CY2023Q4 us-gaap Time Deposit Maturities Next Rolling Twelve Months
TimeDepositMaturitiesNextRollingTwelveMonths
65981000
CY2023Q4 us-gaap Time Deposit Maturities Rolling Year Two
TimeDepositMaturitiesRollingYearTwo
20295000
CY2023Q4 us-gaap Time Deposit Maturities Rolling Year Three
TimeDepositMaturitiesRollingYearThree
2276000
CY2023Q4 us-gaap Time Deposit Maturities Rolling Year Four
TimeDepositMaturitiesRollingYearFour
1600000
CY2023Q4 us-gaap Time Deposit Maturities Rolling Year Five
TimeDepositMaturitiesRollingYearFive
610000
CY2023Q4 cull Demand Account Reclassification To Loans
DemandAccountReclassificationToLoans
102000
CY2022Q4 cull Demand Account Reclassification To Loans
DemandAccountReclassificationToLoans
46000
CY2023Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
35000000
CY2022Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
25000000
CY2023 us-gaap Payments For Federal Home Loan Bank Advances
PaymentsForFederalHomeLoanBankAdvances
15000000
CY2023 cull Recognized Gain Loss
RecognizedGainLoss
127000
CY2022 us-gaap Payments For Federal Home Loan Bank Advances
PaymentsForFederalHomeLoanBankAdvances
18500000
CY2022 cull Recognized Gain Loss
RecognizedGainLoss
87000
CY2023Q4 us-gaap Collateralized Agreements
CollateralizedAgreements
80011000
CY2022Q4 us-gaap Collateralized Agreements
CollateralizedAgreements
83008000
CY2023Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40011000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due Within One Year Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueWithinOneYearOfBalanceSheetDate
0
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From One To Two Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromOneToTwoYearsOfBalanceSheetDate
5000000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Two To Three Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromTwoToThreeYearsOfBalanceSheetDate
10000000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Three To Four Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromThreeToFourYearsOfBalanceSheetDate
10000000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Maturities Summary Due From Four To Five Years Of Balance Sheet Date
FederalHomeLoanBankAdvancesMaturitiesSummaryDueFromFourToFiveYearsOfBalanceSheetDate
10000000
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
10000000
CY2023 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
0
CY2022 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
0
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
966000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
775000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
250000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
178000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1216000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
953000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-94000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
118000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-25000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
30000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-119000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
148000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1097000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1101000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1148000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1001000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
829000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
755000
CY2023Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
105000
CY2022Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
250000
CY2023Q4 us-gaap Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
977000
CY2022Q4 us-gaap Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
946000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
46000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
30000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3105000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2982000
CY2023Q4 cull Deferred Tax Liabilities Fhlb Stock Dividends
DeferredTaxLiabilitiesFHLBStockDividends
-55000
CY2022Q4 cull Deferred Tax Liabilities Fhlb Stock Dividends
DeferredTaxLiabilitiesFHLBStockDividends
-55000
CY2023Q4 cull Deferred Tax Liabilities Loan Fees
DeferredTaxLiabilitiesLoanFees
-11000
CY2022Q4 cull Deferred Tax Liabilities Loan Fees
DeferredTaxLiabilitiesLoanFees
-20000
CY2023Q4 cull Deferred Tax Liabilities Basis Difference In Fixed Assets
DeferredTaxLiabilitiesBasisDifferenceInFixedAssets
-544000
CY2022Q4 cull Deferred Tax Liabilities Basis Difference In Fixed Assets
DeferredTaxLiabilitiesBasisDifferenceInFixedAssets
-569000
CY2023Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
0
CY2022Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
0
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-55000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-49000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
665000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
693000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2440000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2289000
CY2023 cull Retained Earnings Under Internal Revenue Code
RetainedEarningsUnderInternalRevenueCode
1248000
CY2022 cull Retained Earnings Under Internal Revenue Code
RetainedEarningsUnderInternalRevenueCode
1248000
CY2023 cull Deferred Income Taxes Provided
DeferredIncomeTaxesProvided
0
CY2022 cull Deferred Income Taxes Provided
DeferredIncomeTaxesProvided
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1061000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1109000
CY2023 us-gaap Income Tax Reconciliation Tax Settlements State And Local
IncomeTaxReconciliationTaxSettlementsStateAndLocal
178000
CY2022 us-gaap Income Tax Reconciliation Tax Settlements State And Local
IncomeTaxReconciliationTaxSettlementsStateAndLocal
165000
CY2023Q4 cull Effective Income Tax Rate Reconciliation Tax Free Loan Income
EffectiveIncomeTaxRateReconciliationTaxFreeLoanIncome
-63000
CY2022Q4 cull Effective Income Tax Rate Reconciliation Tax Free Loan Income
EffectiveIncomeTaxRateReconciliationTaxFreeLoanIncome
-57000
CY2023 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
79000
CY2022 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
116000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1097000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1101000
CY2023 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2022 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2023 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
The Company and its subsidiary are subject to U.S. federal income tax as well as income tax of the state of Alabama. The Company is no longer subject to examination by taxing authorities for years before 2020.
CY2023 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2020
CY2023 cull Number Of Deferred Compensation Plan
NumberOfDeferredCompensationPlan
2
CY2023 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
702000
CY2022 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
565000
CY2023Q4 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
4123000
CY2022Q4 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
3756000
CY2023 cull Description Of Company Sponsor Deferred Compensation Plan
DescriptionOfCompanySponsorDeferredCompensationPlan
The Company sponsors a profit-sharing plan that covers all employees (salaried and hourly employees who worked 1,000 hours or more) who have one or more years of service. Contributions are 100% vested after three years of service.
CY2023 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
1
CY2023 us-gaap Deferred Compensation Arrangement With Individual Requisite Service Period1
DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
P3Y
CY2023 us-gaap Deferred Compensation Arrangement With Individual Cash Awards Granted Percentage
DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage
0.15
CY2023 us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
616000
CY2022 us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
517000
CY2023 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
234000
CY2022 us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
666000
CY2023 cull Employee Stock Ownership Plan Esop Compensation Expense Including Mark To Market Adjustment Amount
EmployeeStockOwnershipPlanEsopCompensationExpenseIncludingMarkToMarketAdjustmentAmount
222000
CY2022 cull Employee Stock Ownership Plan Esop Compensation Expense Including Mark To Market Adjustment Amount
EmployeeStockOwnershipPlanEsopCompensationExpenseIncludingMarkToMarketAdjustmentAmount
560000
CY2023Q4 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
706864
CY2022Q4 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
688039
CY2023Q4 cull Employee Stock Ownership Plan Esop Number Of Unearned Shares
EmployeeStockOwnershipPlanESOPNumberOfUnearnedShares
282557
CY2022Q4 cull Employee Stock Ownership Plan Esop Number Of Unearned Shares
EmployeeStockOwnershipPlanESOPNumberOfUnearnedShares
303353
CY2023Q4 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
989421
CY2022Q4 us-gaap Employee Stock Ownership Plan Esop Shares In Esop
EmployeeStockOwnershipPlanESOPSharesInESOP
991392
CY2023Q4 us-gaap Employee Stock Ownership Plan Esop Deferred Shares Fair Value
EmployeeStockOwnershipPlanESOPDeferredSharesFairValue
3043000
CY2022Q4 us-gaap Employee Stock Ownership Plan Esop Deferred Shares Fair Value
EmployeeStockOwnershipPlanESOPDeferredSharesFairValue
3486000
CY2023Q4 cull Employee Stock Ownership Plan Esop Deferred Shares Fair Value Per Share
EmployeeStockOwnershipPlanEsopDeferredSharesFairValuePerShare
10.77
CY2022Q4 cull Employee Stock Ownership Plan Esop Deferred Shares Fair Value Per Share
EmployeeStockOwnershipPlanEsopDeferredSharesFairValuePerShare
11.49
CY2023Q4 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.09
CY2023Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
79101000000
CY2023Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.1904
CY2023Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
37384000000
CY2023Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.09
CY2022Q4 us-gaap Tier One Leverage Capital
TierOneLeverageCapital
75221000000
CY2022Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.1775
CY2022Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized
TierOneLeverageCapitalRequiredToBeWellCapitalized
38137000000
CY2022Q4 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.09
CY2023Q4 cull Dividends Yet To Be Declare
DividendsYetToBeDeclare
7136000
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
5928000
CY2023 us-gaap Loans And Leases Receivable Related Parties Additions
LoansAndLeasesReceivableRelatedPartiesAdditions
331000
CY2023 cull Loans And Leases Receivable Related Parties Repayments
LoansAndLeasesReceivableRelatedPartiesRepayments
357000
CY2023Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
5902000
CY2023Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
5057000
CY2022Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
3072000
CY2023Q4 us-gaap Other Real Estate And Foreclosed Assets
OtherRealEstateAndForeclosedAssets
100000
CY2023Q4 us-gaap Transfers Of Financial Assets Accounted For As Sale Initial Fair Value Of Assets Obtained As Proceeds
TransfersOfFinancialAssetsAccountedForAsSaleInitialFairValueOfAssetsObtainedAsProceeds
0
CY2022Q4 us-gaap Transfers Of Financial Assets Accounted For As Sale Initial Fair Value Of Assets Obtained As Proceeds
TransfersOfFinancialAssetsAccountedForAsSaleInitialFairValueOfAssetsObtainedAsProceeds
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
340903
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.86
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M17D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
443249
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.54
CY2023 cull Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Life
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualLife
P9Y9M
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
784152
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.24
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
784152
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
10.24
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y6M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
416000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
204531
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
108000
CY2023Q4 us-gaap Share Price
SharePrice
10.77
CY2023 us-gaap Net Income Loss
NetIncomeLoss
3953000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
4183000
CY2023 us-gaap Distributed Earnings
DistributedEarnings
0
CY2022 us-gaap Distributed Earnings
DistributedEarnings
0
CY2023 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
50000
CY2022 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
54000
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3903000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4129000
CY2023 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
7335933
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
7404951
CY2023 cull Participating Securities
ParticipatingSecurities
119985
CY2022 cull Participating Securities
ParticipatingSecurities
120447
CY2023 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
295263
CY2022 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
338806
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6920685
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6945698
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.56
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3903000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4129000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6920685
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6945698
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
258181
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
60613
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7178866
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7006311
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
136356
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
136356
CY2019Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2023Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0167
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
71000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
59000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
67000
CY2023Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P1Y
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
59000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
0
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
59000
CY2023 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
119000
CY2022 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
119000
CY2023 cull Lessor Operating Lease Remaining Rental Income Term
LessorOperatingLeaseRemainingRentalIncomeTerm
P5Y
CY2023Q4 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
132
CY2023Q4 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
312
CY2023Q4 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
312
CY2023Q4 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
312
CY2023Q4 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
312

Files In Submission

Name View Source Status
0000950170-24-035099-index-headers.html Edgar Link pending
0000950170-24-035099-index.html Edgar Link pending
0000950170-24-035099.txt Edgar Link pending
0000950170-24-035099-xbrl.zip Edgar Link pending
cull-20231231.htm Edgar Link pending
cull-20231231.xsd Edgar Link pending
cull-ex31_1.htm Edgar Link pending
cull-ex31_2.htm Edgar Link pending
cull-ex32.htm Edgar Link pending
cull-20231231_htm.xml Edgar Link completed
cull-ex97_ex97.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img230204345_0.jpg Edgar Link pending
img230204345_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable